| Q38236662 | A practical guide to induced pluripotent stem cell research using patient samples |
| Q64929729 | Anephrogenic phenotype induced by SALL1 gene knockout in pigs. |
| Q48502116 | Apancreatic pigs cloned using Pdx1-disrupted fibroblasts created via TALEN-mediated mutagenesis |
| Q40739191 | Application of hollow fiber vitrification for cryopreservation of bovine early cleavage stage embryos and porcine morula-blastomeres |
| Q85649055 | Assessing the potential of induced liver regeneration |
| Q27309996 | Availability of empty zona pellucida for generating embryonic chimeras |
| Q47596092 | Beta-cell replacement strategies for diabetes |
| Q38645581 | CRISPR Editing in Biological and Biomedical Investigation. |
| Q52431223 | CRISPR Gene Editing in the Kidney. |
| Q41620394 | CRISPR-Cas9 mediated one-step disabling of pancreatogenesis in pigs |
| Q46236955 | CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheep. |
| Q39326062 | Capturing Human Naïve Pluripotency in the Embryo and in the Dish |
| Q36766781 | Chimerism in piglets developed from aggregated cloned embryos. |
| Q92297393 | Compensation of Disabled Organogeneses in Genetically Modified Pig Fetuses by Blastocyst Complementation |
| Q38156153 | Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives |
| Q26738746 | Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research |
| Q48060500 | Creating human organs in chimaera pigs: an ethical source of immunocompatible organs? |
| Q27691323 | Current Bioengineering Methods for Whole Kidney Regeneration |
| Q38770004 | Current Bioengineering and Regenerative Strategies for the Generation of Kidney Grafts on Demand. |
| Q61454001 | Current approaches in regenerative medicine for the treatment of diabetes: introducing CRISPR/CAS9 technology and the case for non-embryonic stem cell therapy |
| Q97527894 | Current progress in stem cell therapy for type 1 diabetes mellitus |
| Q38844310 | Derivation and application of pluripotent stem cells for regenerative medicine |
| Q36097492 | Efficacy of the porcine species in biomedical research |
| Q42336317 | Efficient generation of mouse ESCs-like pig induced pluripotent stem cells |
| Q93066102 | Engineering pancreatic tissues from stem cells towards therapy |
| Q36396291 | Ethical acceptability of research on human-animal chimeric embryos: summary of opinions by the Japanese Expert Panel on Bioethics |
| Q40843392 | Etv2 IS A MASTER REGULATOR OF HEMATOENDOTHELIAL LINEAGES. |
| Q33897291 | Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease |
| Q58706091 | Generating Human Organs via Interspecies Chimera Formation: Advances and Barriers |
| Q36661672 | Generation of Fibroblasts Lacking the Sal-like 1 Gene by Using Transcription Activator-like Effector Nuclease-mediated Homologous Recombination |
| Q57292623 | Generation of Vascular Endothelial Cells and Hematopoietic Cells by Blastocyst Complementation |
| Q48291595 | Generation of chimeric minipigs by aggregating 4- to 8-cell-stage blastomeres from somatic cell nuclear transfer with the tracing of enhanced green fluorescent protein. |
| Q36841472 | Generation of exogenous germ cells in the ovaries of sterile NANOS3-null beef cattle |
| Q91174571 | Generation of functional lungs via conditional blastocyst complementation using pluripotent stem cells |
| Q38985884 | Generation of human organs in pigs via interspecies blastocyst complementation. |
| Q34599892 | Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency |
| Q36215127 | Generation of α1,3-galactosyltransferase and cytidine monophospho-N-acetylneuraminic acid hydroxylase gene double-knockout pigs |
| Q38142738 | Genetically engineered pig models for diabetes research |
| Q58764784 | Genome Editing of Pigs for Agriculture and Biomedicine |
| Q38901709 | Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases |
| Q26751364 | Growing human organs in pigs-A dream or reality? |
| Q89597902 | Hopes and Difficulties for Blastocyst Complementation |
| Q91741758 | Human-animal chimeras for autologous organ transplantation: technological advances and future perspectives |
| Q26746095 | Human-animal chimeras: ethical issues about farming chimeric animals bearing human organs |
| Q53034608 | Humanized organs in gene-edited animals. |
| Q52424972 | Hypomorphic phenotype of Foxn1 gene-modified rats by CRISPR/Cas9 system. |
| Q46256318 | Importance of oil overlay for production of porcine embryos in vitro. |
| Q90929589 | In vitro establishment of expanded-potential stem cells from mouse pre-implantation embryos or embryonic stem cells |
| Q38192859 | In vitro reconstitution of pancreatic islets |
| Q92704107 | Interspecies Organogenesis for Human Transplantation |
| Q26772154 | Liver-Regenerative Transplantation: Regrow and Reset |
| Q27011082 | Livestock models for exploiting the promise of pluripotent stem cells |
| Q47193134 | Modeling lethal X-linked genetic disorders in pigs with ensured fertility. |
| Q90036861 | Modelling the endocrine pancreas in health and disease |
| Q89929952 | Molecular and genetic regulation of pig pancreatic islet cell development |
| Q37044039 | Non-human primate chimeras make a move |
| Q45961885 | Novel strategies for liver therapy using stem cells. |
| Q43031297 | Novel technology for liver regeneration and replacement |
| Q49569055 | Organoid and Organ-On-A-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease |
| Q47837438 | Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering |
| Q36207383 | Pigs pave a way to de novo formation of functional human kidneys |
| Q33682621 | Primate embryogenesis predicts the hallmarks of human naïve pluripotency. |
| Q41189572 | Psoriasiform skin disease in transgenic pigs with high-copy ectopic expression of human integrins α2 and β1 |
| Q52780259 | Public attitudes in Japan towards human-animal chimeric embryo research using human induced pluripotent stem cells. |
| Q42569417 | Recent advances in understanding xenotransplantation: implications for the clinic |
| Q52543005 | Regenerative medicine and cell-based approaches to restore pancreatic function. |
| Q59798018 | Rescuing ocular development in an anophthalmic pig by blastocyst complementation |
| Q36007952 | Rewinding the process of mammalian extinction |
| Q41109196 | Spermatogonial stem cells: Current biotechnological advances in reproduction and regenerative medicine |
| Q37607507 | Stage-specific differential gene expression profiling and functional network analysis during morphogenesis of diphyodont dentition in miniature pigs, Sus Scrofa |
| Q93036319 | Stem Cell-Related Studies and Stem Cell-Based Therapies in Liver Diseases |
| Q47563945 | Stem cells and genome editing: approaches to tissue regeneration and regenerative medicine |
| Q39025388 | Stem cells and interspecies chimaeras |
| Q50503893 | Studies of Pig Complement: Measurement of Pig CH50, ACH50, and Components. |
| Q88942415 | Studies of innate immune systems against human cells |
| Q50421781 | Targeted Mutation of NGN3 Gene Disrupts Pancreatic Endocrine Cell Development in Pigs |
| Q34918516 | Targeted organ generation using Mixl1-inducible mouse pluripotent stem cells in blastocyst complementation |
| Q36936540 | The ethics of killing human/great-ape chimeras for their organs: a reply to Shaw et al. |
| Q34043553 | The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs |
| Q42286926 | Towards Organs on Demand: Breakthroughs and Challenges in Models of Organogenesis |
| Q64235955 | Tracking diphyodont development in miniature pigs and |
| Q33858043 | Transgenic pigs with pancreas-specific expression of green fluorescent protein |
| Q39376012 | Transplantable liver production plan: "Yamaton"--liver project, Japan |
| Q63246521 | Two decades of embryonic stem cells: a historical overview |
| Q36207459 | Urine excretion strategy for stem cell-generated embryonic kidneys |
| Q50005413 | When pig organs will fly. |
| Q39453788 | Xenogeneic chimera-Generated by blastocyst complementation-As a potential unlimited source of recipient-tailored organs. |
| Q47279794 | Xenotransplantation: back to the future? |
| Q39369744 | iPSC technology-based regenerative therapy for diabetes. |